Pre-deposit of excise duty upheld for surgical instrument manufacturer. Sterilizing and packaging needles/syringes qualify as 'manufacture.'

The Tribunal upheld the requirement of pre-deposit of excise duty for the appellant, engaged in manufacturing surgical instruments. The dispute revolved around whether sterilizing and packaging needles/syringes constituted 'manufacture.' The Tribunal found this activity transformed the products into distinct marketable commodities, qualifying as 'manufacture.' The appellant was directed to deposit a specific amount as pre-deposit, with recovery waived upon compliance within a specified timeframe. The Tribunal deemed the appellant's activities as falling within the definition of 'manufacture' under the Central Excise Act, 1944.

---

---

Issues:
Waiver of pre-deposit of excise duty for appeal.

Analysis:
The appellant, engaged in the manufacture and trading of surgical instruments, appealed against the requirement of pre-deposit of excise duty and penalty. The dispute centered around whether the activity of purchasing/importing needles/syringes, sterilizing them, and packaging them in retail packs amounted to 'manufacture' as per Section 2(f) of the Central Excise Act, 1944. The appellant argued that this activity did not constitute 'manufacture,' citing a decision of the Larger Bench of the Tribunal. Conversely, the Department contended that sterilization was an essential process making the product a medical device, thus constituting 'manufacture.' The Tribunal analyzed Section 2(f) and concluded that the activity was incidental and ancillary to the completion of a medical/surgical device, hence amounting to 'manufacture.'

In a previous case, the Tribunal had ruled that packaging various products required for heart surgery did not amount to 'manufacture' as no new product emerged from the process. However, in a different case, it was held that syringes and needles, post-sterilization, became distinct marketable commodities, constituting 'manufacture.' Drawing parallels, the Tribunal found that the needles and syringes, after sterilization, transformed into distinct marketable commodities, thus qualifying as 'manufacture' in the present case. Consequently, the Tribunal directed the appellant to deposit a specific amount as pre-deposit to maintain the appeal, with the balance amount's recovery waived upon compliance within a specified timeframe.

In conclusion, the Tribunal upheld the requirement of pre-deposit of a certain amount for excise duty, considering the activity of the appellant as falling within the ambit of 'manufacture' under the Central Excise Act, 1944.

---